The Technical Analyst
Outset Medical, Inc. [OM]
Exchange: NASDAQ Sector: Healthcare Industry: Medical Devices
Outset Medical, Inc. Price, Forecast, Insider, Ratings, Fundamentals & Signals
Current Signal: BUY (auto-tracking)
2.67% $2.31
America/New_York / 19 apr 2024 @ 09:53
| FUNDAMENTALS | |
|---|---|
| MarketCap: | 116.68 mill |
| EPS: | -3.48 |
| P/E: | -0.660 |
| Earnings Date: | May 01, 2024 |
| SharesOutstanding: | 50.51 mill |
| Avg Daily Volume: | 0.972 mill |
| RATING 2024-04-18 |
|---|
| B+ |
| Neutral |
| RATINGS | ||
|---|---|---|
| Rating CashFlow: | Neutral | |
| Return On Equity: | Strong Sell | |
| Return On Asset: | Sell | |
| DE: | Strong Buy | |
| P/E: | Neutral | |
| Price To Book: | Buy |
| QUARTER GROWTHS | ||||||
|---|---|---|---|---|---|---|
| 3/22 | 4/22 | 1/23 | 2/23 | 3/23 | 4/23 | |
| Revenue | ||||||
| Gr.Profit | ||||||
| Ebit | ||||||
| Asset | ||||||
| Debt |
| PE RATIO: COMPANY / SECTOR |
|---|
| 0.00x |
| Company: PE -0.660 | sector: PE -3.05 |
| PE RATIO: COMPANY / INDUSTRY |
|---|
| 0.00x |
| Company: PE -0.660 | industry: PE 222.16 |
| DISCOUNTED CASH FLOW VALUE |
|---|
| N/A |
| N/A |
| Expected Trading Range (DAY) |
|---|
|
$ 2.07 - 2.58 ( +/- 10.84%) |
| ATR Model: 14 days |
Insider Trading
| Date | Person | Action | Amount | type |
|---|---|---|---|---|
| 2024-03-15 | Nash Marc | Sell | 2 391 | Common Stock |
| 2024-03-12 | Lang Brent D. | Buy | 108 024 | Common Stock |
| 2024-03-12 | Lang Brent D. | Buy | 0 | |
| 2024-02-29 | Ahmed Nabeel | Buy | 1 584 | Common Stock |
| 2024-03-01 | Ahmed Nabeel | Sell | 1 584 | Common Stock |
| INSIDER POWER |
|---|
| 73.62 |
| Last 99 transactions |
| Buy: 1 908 258 | Sell: 337 016 |
Forecast:
11:32 - $2.27
Live Trading Signals (every 1 min)
Forecast
1: 10:02 - $2.33
Forecast 2: 10:52 - $2.28
Forecast 3: 11:32 - $2.27
SCORE
10.00
Buy
10.00
Buy
Score Algorithm Version: 1.2C
Last version updated: Fri April 15th, 2022
Last version updated: Fri April 15th, 2022
| Indicator Signals | |
|---|---|
| RSI 21 | |
| SMA | |
| Trend | |
| Trend 2 | |
| Trend 3 | |
| MACD |
| Volume Signals | |
|---|---|
| Price | $2.31 (2.67% ) |
| Volume | 0.109 mill |
| Avg. Vol. | 0.972 mill |
| % of Avg. Vol | 11.27 % |
| Signal 1: | |
| Signal 2: |
Today
Last 12 Months
RSI
Last 10 Buy & Sell Signals For OM
0 Signals | Accuracy: 0.00% | Accuracy Buy: 0.00% | Accuracy Sell: 0.00%
Avg return buy: 0.00 % | Avg return sell: 0.00 %
$1 invested is now $1.00 or 0.00% since Coming Soon
| Date | Signal | @ | Closed | % | Feb 8 - 15:35 | sell | $3.29 | N/A | Active |
|---|
OM
Outset Medical, Inc., a medical technology company, develops a hemodialysis system for dialysis. It provides the Tablo Hemodialysis System, which comprises a compact console with integrated water purification, on-demand dialysate production, and software and connectivity capabilities for dialysis care in acute and home settings. The company was formerly known as Home Dialysis Plus, Ltd. and changed its name to Outset Medical, Inc. in January 2015. Outset Medical, Inc. was incorporated in 2003 and is headquartered in San Jose, California.
Last 10 Buy Signals
Latest Press Releases
2024-04-19 08:30:00 - Press Release
Outset Medical To Report First Quarter 2024 Financial Results On Wednesday, May 8, 2024
San jose, calif.--(business wire)--outset medical, inc. (nasdaq: om) (“outset”), a medical technology company pioneering a first-of-its-kind technology to reduce the cost and complexity of dialysis, today announced that it will release financial results for the first quarter of 2024 after the close of trading on wednesday, may 8, 2024. on the same day, at 2:00 p.m. pacific time (5:00 p.m. eastern time), leslie trigg, chair and chief executive officer, and nabeel ahmed, chief financial officer,.
2024-04-17 08:30:00 - Press Release
Outset Medical And U.s. Renal Care Announce Multi-year Agreement To Accelerate And Grow Home Dialysis Across The U.s.
San jose, calif.--(business wire)--outset medical, inc. (nasdaq: om) (“outset”), a medical technology company pioneering a first-of-its-kind technology to reduce the cost and complexity of dialysis, and u.s. renal care, the largest privately held kidney care provider in the united states, announced today a multi-year agreement to help accelerate home hemodialysis in the u.s. studies show patients with end-stage kidney disease (eskd) are healthier mentally and physically dialyzing at home, more.
2024-04-15 08:30:00 - Press Release
Outset Medical Partners With American Nephrology Nurses Association To Support Nephrology Nursing And Patient Care
San jose, calif.--(business wire)--outset medical, inc. (nasdaq: om) (“outset”), a medical technology company pioneering a first-of-its-kind technology to reduce the cost and complexity of dialysis, today announced its partnership with the american nephrology nurses association (anna) as a member of its new partnership advisory council. this collaboration underscores outset's dedication to supporting the nephrology nursing community and improving patient care in the realm of kidney disease. les.
2024-03-13 16:02:00 - Press Release
Outset Medical Announces Appointment Of Medical Technology Veteran Brent D. Lang To Its Board Of Directors
San jose, calif.--(business wire)--outset medical, inc. (nasdaq: om) (“outset”), a medical technology company pioneering a first-of-its-kind technology to reduce the cost and complexity of dialysis, today announced the appointment of medical technology veteran brent d. lang to its board of directors. mr. lang most recently served as chairman and chief executive officer of vocera communications, a global provider of clinical communication and workflow solutions, until its acquisition by stryker.
2024-02-26 09:00:00 - Press Release
Outset Medical To Present At The 44th Annual Td Cowen Health Care Conference
San jose, calif.--(business wire)--outset medical, inc. (nasdaq: om) (“outset”), a medical technology company pioneering a first-of-its-kind technology to reduce the cost and complexity of dialysis, today announced that members of management will present at the 44th annual td cowen health care conference on tuesday, march 5, 2024, at 1:30 p.m. eastern time. a live and archived webcast of the presentation will be available on the “investors” section of the outset website at https://investors.out.
Latest News
2024-04-19 08:30:00 - Business Wire
Outset Medical to Report First Quarter 2024 Financial Results on Wednesday, May 8, 2024
SAN JOSE, Calif.--(BUSINESS WIRE)--Outset Medical, Inc. (Nasdaq: OM) (“Outset”), a medical technology company pioneering a first-of-its-kind technology to reduce the cost and complexity of dialysis, today announced that it will release financial results for the first quarter of 2024 after the close of trading on Wednesday, May 8, 2024. On the same day, at 2:00 p.m. Pacific time (5:00 p.m. Eastern time), Leslie Trigg, Chair and Chief Executive Officer, and Nabeel Ahmed, Chief Financial Officer,.
2024-04-18 14:41:05 - Zacks Investment Research
Outset Medical (OM) Inks Multi-Year Deal to Boost Home Dialysis
Outset Medical's (OM) latest agreement is likely to provide patients and caregivers access to innovative home dialysis with the Tablo Hemodialysis System.
2024-02-21 23:59:09 - Seeking Alpha
Outset Medical, Inc. (OM) Q4 2023 Earnings Call Transcript
2024-02-05 11:05:28 - Zacks Investment Research
Outset Medical, Inc. (OM) Expected to Beat Earnings Estimates: Should You Buy?
Outset Medical, Inc. (OM) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
2024-02-05 08:30:00 - Business Wire
Outset Medical to Report Fourth Quarter and Full-Year 2023 Financial Results on Wednesday, February 21, 2024
SAN JOSE, Calif.--(BUSINESS WIRE)--Outset Medical, Inc. (Nasdaq: OM) (“Outset”), a medical technology company pioneering a first-of-its-kind technology to reduce the cost and complexity of dialysis, today announced that it will release financial results for the fourth quarter and full-year 2023 after the close of trading on Wednesday, February 21, 2024. On the same day, at 2:00 p.m. Pacific time (5:00 p.m. Eastern time), Leslie Trigg, Chair and Chief Executive Officer, and Nabeel Ahmed, Chief F.
2023-11-29 16:05:00 - Business Wire
Outset Medical to Present at BofA Home Care Conference
SAN JOSE, Calif.--(BUSINESS WIRE)--Outset Medical, Inc. (Nasdaq: OM) (“Outset”), a medical technology company pioneering a first-of-its-kind technology to reduce the cost and complexity of dialysis, today announced that members of management will participate in a virtual panel discussion at the BofA Securities Home Care Conference on Monday, December 4, 2023, at 12:00pm PT / 3:00pm ET. The panel discussion will include Leslie Trigg, Outset's Chair and Chief Executive Officer, Michael Aragon, MD.
2023-11-25 11:43:00 - The Motley Fool
5 Struggling Stocks to Buy at a Discount
These five companies have glimmers of hope that the market has yet to fully recognize. Each is trading at a significant discount to recent highs.
2023-11-23 06:30:00 - The Motley Fool
2 of the Cheapest Stocks I Own
Target has moved past its inventory woes and is showing positive signs. Outset Medical has faced setbacks, but still has a long runway for growth.
2023-11-02 11:26:07 - Zacks Investment Research
After Plunging -62.36% in 4 Weeks, Here's Why the Trend Might Reverse for Outset Medical, Inc. (OM)
Outset Medical, Inc. (OM) has become technically an oversold stock now, which implies exhaustion of the heavy selling pressure on it. This, combined with strong agreement among Wall Street analysts in revising earnings estimates higher, indicates a potential trend reversal for the stock in the near term.
2023-10-17 11:19:34 - Zacks Investment Research
Down -68.16% in 4 Weeks, Here's Why You Should You Buy the Dip in Outset Medical, Inc. (OM)
The heavy selling pressure might have exhausted for Outset Medical, Inc. (OM) as it is technically in oversold territory now. In addition to this technical measure, strong agreement among Wall Street analysts in revising earnings estimates higher indicates that the stock is ripe for a trend reversal.